Skip to content

Effect of Normal Aging on Language Processing

Cognitive Mechanisms and Cerebral Substrate of Naming Impairment During Aging. Behavior and Neuroimaging Approaches.

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02189460
Acronym
SEMVIE
Enrollment
33
Registered
2014-07-14
Start date
2014-07-31
Completion date
2018-07-31
Last updated
2018-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognition

Keywords

Cognition

Brief summary

The purpose of this study is to understand the effect of age on language abilities. The investigators aim at investigating the cerebral modifications that take place in normal aging, at the functional an anatomical level.

Interventions

None listed

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age of 30 years and above * Right handed * French native speakers * Affiliation to French social security (Sécurité Sociale) * Medical interview * Consent form signed

Exclusion criteria

* Cerebral or respiratory pathologies * Any MRI contrindication

Design outcomes

Primary

MeasureTime frameDescription
Blood Oxygen Level Dependent functional MRIThere will be a unique MRI measurement for each participant. Group analyses presentation after 1 year.We use 3 functional tasks using block paradigm: Object naming, Verbal generation and semantic judgment, to elicit BOLD response using fMRI in order to compare functional activation patterns between subjects. We also use hypercapnic challenge to elicit BOLD response in order to obtain Cerebral Vascular Reactivity properties of subjects.
Anatomical MRIThere will be a unique MRI measurement for each participant. Group analyses presentation after 1 year.We use Voxel Based Morphometry to compare cortical volume (grey matter) between subjects. We also use tractography Diffusion Tensor Imaging to compare white matter properties between subjects.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026